Current and emerging clinical applications of PSMA PET diagnostic imaging for prostate cancer

A Farolfi, L Calderoni, F Mattana, R Mei… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) is highly expressed on most prostate cancer
(PCa) cells, and several PSMA ligands for PET imaging are now available worldwide. 68Ga …

Using PSMA imaging for prognostication in localized and advanced prostate cancer

MJ Roberts, T Maurer, M Perera, M Eiber… - Nature Reviews …, 2023 - nature.com
The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …

Targeting PSMA revolutionizes the role of nuclear medicine in diagnosis and treatment of prostate cancer

WI Luining, MCF Cysouw, D Meijer, NH Hendrikse… - Cancers, 2022 - mdpi.com
Simple Summary Imaging plays a crucial role in the accurate staging of prostate cancer.
Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer cells, and …

The role of PSMA PET/CT in the primary diagnosis and follow-up of prostate cancer—a practical clinical review

AR Lisney, C Leitsmann, A Strauß, B Meller… - Cancers, 2022 - mdpi.com
Simple Summary The combination of positron emission tomography (PET)-diagnostics with
ligands binding to the prostate-specific membrane antigen (PSMA) has been a diagnostic …

Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?

MJ Roberts, JW Yaxley, J Stranne… - Prostate Cancer and …, 2024 - nature.com
An extended pelvic lymph node dissection (ePLND) at time of radical prostatectomy remains
a recommended approach by most international prostate cancer guidelines. Enthusiasts for …

[HTML][HTML] Detection of recurrence sites using 18F-fluorocholine PET/CT in prostate cancer patients with PSA failure

DY Kim, WW Lee, YS Song, SK Hong, SS Byun… - Prostate …, 2023 - Elsevier
Background The optimal condition for the clinical application of 18 F-fluorocholine positron
emission tomography–computed tomography (FCH-PET/CT) to detect recurrence sites in …

Predictors of Bone Metastases at 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence

G Rovera, S Grimaldi, S Dall'Armellina, R Passera… - Diagnostics, 2022 - mdpi.com
Prostate-specific-membrane-antigen/positron-emission-tomography (PSMA-PET) can
accurately detect disease localizations in prostate cancer (PCa) patients with early …

Predicting early outcomes in patients with intermediate‐and high‐risk prostate cancer using prostate‐specific membrane antigen positron emission tomography and …

D Meijer, PJ van Leeuwen, ML Donswijk… - BJU …, 2022 - Wiley Online Library
Objectives To identify predictors of early oncological outcomes in patients who opt for robot‐
assisted laparoscopic radical prostatectomy (RARP) for localized prostate cancer (PCa) …

Posttreatment Lower Urinary Tract and Prostate Imaging

MU Nisar, AS Purysko, RD Ward - Urologic Clinics, 2024 - urologic.theclinics.com
The lower urinary tract includes the distal ureters, bladder, and urethra, and in male
individuals, the prostate gland and seminal vesicles are also typically considered part of this …

The effect of salvage radiation therapy on survival, functional outcomes, and quality of life in men with persistent prostate-specific antigen after robot-assisted radical …

O Özman, AC Berrens, F Pos, PJ van Leeuwen… - Practical Radiation …, 2022 - Elsevier
Purpose The aim of this study was to evaluate the effect of salvage radiation therapy (sRT)
on survival, functional outcomes, and quality of life in men with persistent prostate-specific …